Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Lingying Wu"'
Autor:
Rong Li, Hongping Zhang, Qingshui Li, Guangwen Yuan, Yanjie Zhou, Rutie Yin, He Wang, Chunyan Wang, Yi Huang, Wei Wang, Xiaojian Yan, Lingying Wu, Qi Zhou
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 2, Pp 135-141 (2024)
Background: The paclitaxel liposome formulation, encapsulating paclitaxel within a phospholipid bilayer, addresses the insolubility of traditional paclitaxel formulations, thereby reducing toxicity without compromising its antitumor efficacy. Methods
Externí odkaz:
https://doaj.org/article/103eca0690ea441c9342d6bbcd7c7ead
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Objectives This retrospective study aims to evaluating the subsequent management and outcomes after first-line PARPi progression in Chinese ovarian cancer population. Methods Clinical and pathologic variables, treatment modalities, and outco
Externí odkaz:
https://doaj.org/article/beda6e9de0b14971852ea7db90148f09
Autor:
Baoyuan Zhang, Ning Li, Jiaming Gao, Yuxi Zhao, Jun Jiang, Shuang Xie, Cuiping Zhang, Qingyu Zhang, Leo Liu, Zaiqi Wang, Dongmei Ji, Lingying Wu, Ruibao Ren
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-21 (2024)
Abstract Backgrounds Immune checkpoint blockade (ICB) is widely considered to exert long-term treatment benefits by activating antitumor immunity. However, many cancer patients show poor clinical responses to ICB due in part to the lack of an immunog
Externí odkaz:
https://doaj.org/article/f6130e669747441399b8af4774e9863a
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background Most patients with ovarian cancer (OC) treated with platinum-based chemotherapy have a dismal prognosis owing to drug resistance. However, the regulatory mechanisms of circular RNA (circRNA) and p53 ubiquitination are unknown in p
Externí odkaz:
https://doaj.org/article/9621071e1578457487d86e59f183375d
Autor:
Wenbin Li, Lin Gao, Xin Yi, Shuangfeng Shi, Jie Huang, Leming Shi, Xiaoyan Zhou, Lingying Wu, Jianming Ying
Publikováno v:
Genomics, Proteomics & Bioinformatics, Vol 21, Iss 5, Pp 962-975 (2023)
Defects in genes involved in the DNA damage response cause homologous recombination repair deficiency (HRD). HRD is found in a subgroup of cancer patients for several tumor types, and it has a clinical relevance to cancer prevention and therapies. Ac
Externí odkaz:
https://doaj.org/article/b7c25fd985ea486b8e413214da343df5
Autor:
Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun Song
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-9 (2023)
Abstract Background The therapeutic effect of poly (ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance were inconclusive in
Externí odkaz:
https://doaj.org/article/8e7ef6a125174ca0be522d3c813836b7
Autor:
Jing Yu, Zhenlong Yuan, Jing Liu, Lu Deng, Yuting Zhao, Shengnan Wang, Enyu Tang, Xi Yang, Ning Li, Jusheng An, Lingying Wu
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1468 (2024)
Cervical squamous cell carcinoma (CSCC) represents a significant global health concern among females. Identifying new biomarkers and therapeutic targets is pivotal for improving the prognosis of CSCC. This study investigates the prognostic relevance
Externí odkaz:
https://doaj.org/article/7870ba322b3a454a848e204ba8a3345c
Autor:
Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qinglei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-17 (2023)
Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors are one of the most exciting classes of targeted therapy agents for cancers with homologous recombination (HR) deficiency. However, many patients without apparent HR defects also respond well to
Externí odkaz:
https://doaj.org/article/cca68174bd0f4c47bca6a90059d0f268
Autor:
Jia Zeng, Jing Zuo, Ning Li, HongWen Yao, YuanYuan Zhang, YuXi Zhao, TianTian Wang, Lin Xiu, Jian Li, Jing Yu, LeiLei Liang, LingYing Wu
Publikováno v:
BMC Women's Health, Vol 23, Iss 1, Pp 1-8 (2023)
Highlights 1. The relationship between postoperative HPV infection and cervical cancer recurrences was explored for the first time. 2. The genotypes and viral loads of 15 types of HR-HPV were determined. 3. Continuous HR-HPV positivity after surgery
Externí odkaz:
https://doaj.org/article/5538a8c3c51a4bab89d3fc385d3f53f7
Autor:
Baoyuan Zhang, Ning Li, Jiaming Gao, Yuxi Zhao, Jun Jiang, Shuang Xie, Cuiping Zhang, Qingyu Zhang, Leo Liu, Zaiqi Wang, Dongmei Ji, Lingying Wu, Ruibao Ren
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/271b108b001b4fa19b7c384d303290b8